153 related articles for article (PubMed ID: 14529944)
1. The influence of calcineurin inhibitors on mycophenolic acid pharmacokinetics.
Kuriata-Kordek M; Boratynska M; Falkiewicz K; Porazko T; Urbaniak J; Wozniak M; Patrzalek D; Szyber P; Klinger M
Transplant Proc; 2003 Sep; 35(6):2369-71. PubMed ID: 14529944
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetics of mycophenolic acid and its glucuronide metabolites in stable adult liver transplant recipients with renal dysfunction on a low-dose calcineurin inhibitor regimen and mycophenolate mofetil.
Beckebaum S; Armstrong VW; Cicinnati VR; Streit F; Klein CG; Gerken G; Paul A; Oellerich M
Ther Drug Monit; 2009 Apr; 31(2):205-10. PubMed ID: 19307937
[TBL] [Abstract][Full Text] [Related]
3. Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings.
Zucker K; Rosen A; Tsaroucha A; de Faria L; Roth D; Ciancio G; Esquenazi V; Burke G; Tzakis A; Miller J
Transpl Immunol; 1997 Sep; 5(3):225-32. PubMed ID: 9402690
[TBL] [Abstract][Full Text] [Related]
4. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
[TBL] [Abstract][Full Text] [Related]
5. Effect of cyclosporine on mycophenolic acid trough levels in kidney transplant recipients.
Gregoor PJ; de Sévaux RG; Hené RJ; Hesse CJ; Hilbrands LB; Vos P; van Gelder T; Hoitsma AJ; Weimar W
Transplantation; 1999 Nov; 68(10):1603-6. PubMed ID: 10589962
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolic acid pharmacokinetics in pediatric liver transplant recipients.
Aw MM; Brown NW; Itsuka T; Gonde CE; Adams JE; Heaton ND; Tredger JM; Mieli-Vergani G; Dhawan A
Liver Transpl; 2003 Apr; 9(4):383-8. PubMed ID: 12682891
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of mycophenolic acid in kidney transplant patients receiving sirolimus versus cyclosporine.
El Haggan W; Ficheux M; Debruyne D; Rognant N; Lobbedez T; Allard C; Coquerel A; Ryckelynck JP; Hurault de Ligny B
Transplant Proc; 2005 Mar; 37(2):864-6. PubMed ID: 15848558
[TBL] [Abstract][Full Text] [Related]
8. Best single time points to predict the area-under-the-curve in long-term heart transplant patients taking mycophenolate mofetil in combination with cyclosporine or tacrolimus.
Mardigyan V; Giannetti N; Cecere R; Besner JG; Cantarovich M
J Heart Lung Transplant; 2005 Oct; 24(10):1614-8. PubMed ID: 16210138
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of tacrolimus and cyclosporine on the pharmacokinetics of mycophenolic acid.
van Gelder T; Klupp J; Barten MJ; Christians U; Morris RE
Ther Drug Monit; 2001 Apr; 23(2):119-28. PubMed ID: 11294511
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mycophenolic acid pharmacokinetic parameters in kidney transplant patients within the first 3 months post-transplant.
Pawinski T; Durlik M; Szlaska I; Urbanowicz A; Majchrnak J; Gralak B
J Clin Pharm Ther; 2006 Feb; 31(1):27-34. PubMed ID: 16476117
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of mycophenolate mofetil in Omani patients on cyclosporine or tacrolimus.
Mohsin N; Al-Raisi F; Militsala E; Kamble P; Abdel Razek E; Baddruddin M
Transplant Proc; 2015 May; 47(4):1122-4. PubMed ID: 26036534
[TBL] [Abstract][Full Text] [Related]
12. Renal graft function and low-dose cyclosporine affect mycophenolic acid pharmacokinetics in kidney transplantation.
Cortinovis M; Gotti E; Pradini S; Gaspari F; Perico N
Transplantation; 2011 Sep; 92(5):550-6. PubMed ID: 21709602
[TBL] [Abstract][Full Text] [Related]
13. A randomized trial with steroids and antithymocyte globulins comparing cyclosporine/azathioprine versus tacrolimus/mycophenolate mofetil (CATM2) in renal transplantation.
Vacher-Coponat H; Moal V; Indreies M; Purgus R; Loundou A; Burtey S; Brunet P; Moussi-Frances J; Daniel L; Dussol B; Berland Y
Transplantation; 2012 Feb; 93(4):437-43. PubMed ID: 22228415
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus.
Jain A; Venkataramanan R; Hamad IS; Zuckerman S; Zhang S; Lever J; Warty VS; Fung JJ
J Clin Pharmacol; 2001 Mar; 41(3):268-76. PubMed ID: 11269567
[TBL] [Abstract][Full Text] [Related]
15. UGT1A9 -275T>A/-2152C>T polymorphisms correlate with low MPA exposure and acute rejection in MMF/tacrolimus-treated kidney transplant patients.
van Schaik RH; van Agteren M; de Fijter JW; Hartmann A; Schmidt J; Budde K; Kuypers D; Le Meur Y; van der Werf M; Mamelok R; van Gelder T
Clin Pharmacol Ther; 2009 Sep; 86(3):319-27. PubMed ID: 19494809
[TBL] [Abstract][Full Text] [Related]
16. Effect of cyclosporine on steady-state pharmacokinetics of MPA in renal transplant recipients is not affected by the MPA formulation: analysis based on therapeutic drug monitoring data.
Trkulja V; Lalić Z; Nađ-Škegro S; Lebo A; Granić P; Lovrić M; Pasini J; Božina N
Ther Drug Monit; 2014 Aug; 36(4):456-64. PubMed ID: 24518562
[TBL] [Abstract][Full Text] [Related]
17. Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation.
Mardigyan V; Tchervenkov J; Metrakos P; Barkun J; Deschenes M; Cantarovich M
Clin Ther; 2005 Apr; 27(4):463-9. PubMed ID: 15922819
[TBL] [Abstract][Full Text] [Related]
18. Chronopharmacokinetics of mycophenolic acid and its glucuronide and acyl glucuronide metabolites in kidney transplant recipients converted from cyclosporine to everolimus.
Tedesco-Silva H; Felipe CR; Slade A; Schmouder RL; Medina Pestana JO
Ther Drug Monit; 2012 Dec; 34(6):652-9. PubMed ID: 23131696
[TBL] [Abstract][Full Text] [Related]
19. Impact of changing from cyclosporine to tacrolimus on pharmacokinetics of mycophenolic acid in renal transplant recipients with diabetes.
Park JM; Lake KD; Cibrik DM
Ther Drug Monit; 2008 Oct; 30(5):591-6. PubMed ID: 18708992
[TBL] [Abstract][Full Text] [Related]
20. Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring.
de Winter BC; Mathot RA; Sombogaard F; Vulto AG; van Gelder T
Clin J Am Soc Nephrol; 2011 Mar; 6(3):656-63. PubMed ID: 21088289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
